{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:19:26Z","timestamp":1759666766457},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T00:00:00Z","timestamp":1415750400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s12094-014-1254-y","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T17:33:14Z","timestamp":1415986394000},"page":"438-445","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors"],"prefix":"10.1007","volume":"17","author":[{"given":"L.","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,12]]},"reference":[{"key":"1254_CR1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/1097-0142(19800101)45:1<149::AID-CNCR2820450125>3.0.CO;2-A","volume":"45","author":"DJ Pritchard","year":"1980","unstructured":"Pritchard DJ, Lunke RJ, Taylor WF, Dahlin DC, Medley BE. Chondrosarcoma: a clinicopathologic and statistical analysis. Cancer. 1980;45:149\u201357.","journal-title":"Cancer"},{"key":"1254_CR2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4184\/asj.2014.8.1.84","volume":"8","author":"V Sekharappa","year":"2014","unstructured":"Sekharappa V, Amritanand R, Krishnan V, David KS. Symptomatic solitary osteochondroma of the subaxial cervical spine in a 52-year-old patient. Asian Spine J. 2014;8:84\u20138.","journal-title":"Asian Spine J"},{"key":"1254_CR3","first-page":"405437","volume":"2011","author":"MJ Kim","year":"2011","unstructured":"Kim MJ, Cho KJ, Ayala AG, Ro JY. Chondrosarcoma: with updates on molecular genetics. Sarcoma. 2011;2011:405437.","journal-title":"Sarcoma"},{"key":"1254_CR4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ijc.27984","volume":"133","author":"CE Ford","year":"2013","unstructured":"Ford CE, Qian Ma SS, Quadir A, Ward RL. The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis. Int J Cancer. 2013;133:779\u201387.","journal-title":"Int J Cancer"},{"key":"1254_CR5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrm3470","volume":"13","author":"C Niehrs","year":"2012","unstructured":"Niehrs C. The complex world of WNT receptor signaling. Nat Rev Mol Cell Biol. 2012;13:767\u201379.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1254_CR6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2443.2011.01487.x","volume":"16","author":"D Ren","year":"2011","unstructured":"Ren D, Minami Y, Nishita M. Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following snail-mediated epithelial-mesenchymal transition. Genes Cells. 2011;16:304\u201315.","journal-title":"Genes Cells"},{"key":"1254_CR7","first-page":"785","volume":"20","author":"T Saitoh","year":"2002","unstructured":"Saitoh T, Mine T, Katoh M. Molecular cloning and expression of proto-oncogene FRAT1 in human cancer. Int J Oncol. 2002;20:785\u20139.","journal-title":"Int J Oncol"},{"key":"1254_CR8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/onc.2009.310","volume":"29","author":"R Amerongen van","year":"2010","unstructured":"van Amerongen R, Nawijn MC, Lambooij JP, Proost N, Jonkers J, Berns A. Frat oncoproteins act at the crossroad of canonical and noncanonical Wnt-signaling pathways. Oncogene. 2010;29:93\u2013104.","journal-title":"Oncogene"},{"key":"1254_CR9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/bonekey.2013.112","volume":"2","author":"D Heymann","year":"2013","unstructured":"Heymann D, R\u00e9dini F. Targeted therapies for bone sarcomas. Bonekey Rep. 2013;2:378.","journal-title":"Bonekey Rep"},{"key":"1254_CR10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/onc.2009.305","volume":"29","author":"MP O\u2019Connell","year":"2010","unstructured":"O\u2019Connell MP, Fiori JL, Xu M, Carter AD, Frank BP, Camilli TC, et al. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene. 2010;29:34\u201344.","journal-title":"Oncogene"},{"key":"1254_CR11","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1038\/onc.2009.116","volume":"28","author":"TM Wright","year":"2009","unstructured":"Wright TM, Brannon AR, Gordan JD, Mikels AJ, Mitchell C, Chen S, et al. Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma. Oncogene. 2009;28:2513\u201323.","journal-title":"Oncogene"},{"key":"1254_CR12","first-page":"523","volume":"18","author":"Y Katoh","year":"2006","unstructured":"Katoh Y, Katoh M. Comparative integromics on FAT1, FAT2, FAT3 and FAT4. Int J Mol Med. 2006;18:523\u20138.","journal-title":"Int J Mol Med"},{"key":"1254_CR13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/path.3986","volume":"227","author":"B Edris","year":"2012","unstructured":"Edris B, Espinosa I, M\u00fchlenberg T, Mikels A, Lee CH, Steigen SE, et al. ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour. J Pathol. 2012;227:223\u201333.","journal-title":"J Pathol"},{"key":"1254_CR14","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3892\/mmr.2012.772","volume":"5","author":"BJ Lu","year":"2012","unstructured":"Lu BJ, Wang YQ, Wei XJ, Rong LQ, Wei D, Yan CM, et al. Expression of WNT-5a and ROR2 correlates with disease severity in osteosarcoma. Mol Med Rep. 2012;5:1033\u20136.","journal-title":"Mol Med Rep"},{"key":"1254_CR15","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1349-7006.2009.01165.x","volume":"100","author":"K Morioka","year":"2009","unstructured":"Morioka K, Tanikawa C, Ochi K, Daigo Y, Katagiri T, Kawano H, et al. Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma. Cancer Sci. 2009;100:1227\u201333.","journal-title":"Cancer Sci"},{"key":"1254_CR16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1476-4598-9-170","volume":"9","author":"E Lara","year":"2010","unstructured":"Lara E, Calvanese V, Huidobro C, Fern\u00e1ndez AF, Moncada-Pazos A, Obaya AJ, et al. Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer. Mol Cancer. 2010;9:170.","journal-title":"Mol Cancer"},{"key":"1254_CR17","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3748\/wjg.v18.i12.1328","volume":"18","author":"M Geng","year":"2012","unstructured":"Geng M, Cao YC, Chen YJ, Jiang H, Bi LQ, Liu XH. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. World J Gastroenterol. 2012;18:1328\u201338.","journal-title":"World J Gastroenterol"},{"key":"1254_CR18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3109\/10428194.2012.731599","volume":"54","author":"AH Daneshmanesh","year":"2013","unstructured":"Daneshmanesh AH, Porwit A, Hojjat-Farsangi M, Jeddi-Tehrani M, Tamm KP, Grand\u00e9r D, et al. Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies. Leuk Lymphoma. 2013;54:843\u201350.","journal-title":"Leuk Lymphoma"},{"key":"1254_CR19","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1242\/jcs.097782","volume":"125","author":"M Endo","year":"2012","unstructured":"Endo M, Doi R, Nishita M, Minami Y. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex. Cell Sci. 2012;125:2017\u201329.","journal-title":"Cell Sci"},{"key":"1254_CR20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s004270100140","volume":"211","author":"R Al-Shawi","year":"2001","unstructured":"Al-Shawi R, Ashton SV, Underwood C, Simons JP. Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development. Dev Genes Evol. 2001;211:161\u201371.","journal-title":"Dev Genes Evol"},{"key":"1254_CR21","first-page":"311","volume":"19","author":"T Saitoh","year":"2001","unstructured":"Saitoh T, Katoh M. FRAT1 and FRAT2, clustered in human chromosome 10q24.1 region, are up-regulated in gastric cancer. Int J Oncol. 2001;19:311\u20135.","journal-title":"Int J Oncol"},{"key":"1254_CR22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1101\/gad.326705","volume":"19","author":"R Amerongen van","year":"2005","unstructured":"van Amerongen R, Nawijn M, Franca-Koh J, Zevenhoven J, van der Gulden H, Jonkers J, et al. Frat is dispensable for canonical Wnt signaling in mammals. Genes Dev. 2005;19:425\u201330.","journal-title":"Genes Dev"},{"key":"1254_CR23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ijc.23600","volume":"123","author":"Y Wang","year":"2008","unstructured":"Wang Y, Liu S, Zhu H, Zhang W, Zhang G, Zhou X, et al. FRAT1 overexpression leads to aberrant activation of beta-catenin\/TCF pathway in esophageal squamous cell carcinoma. Int J Cancer. 2008;123:561\u20138.","journal-title":"Int J Cancer"},{"key":"1254_CR24","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s13277-012-0394-3","volume":"33","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Han Y, Zheng R, Yu JH, Miao Y, Wang L, et al. Expression of Frat1 correlates with expression of \u03b2-catenin and is associated with a poor clinical outcome in human SCC and AC. Tumour Biol. 2012;33:1437\u201344.","journal-title":"Tumour Biol"},{"key":"1254_CR25","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/sj.bjc.6602988","volume":"94","author":"Y Wang","year":"2006","unstructured":"Wang Y, Hewitt SM, Liu S, Zhou X, Zhu H, Zhou C, et al. Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumours. Br J Cancer. 2006;94:686\u201391.","journal-title":"Br J Cancer"},{"key":"1254_CR26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainres.2010.01.037","volume":"1320","author":"G Guo","year":"2010","unstructured":"Guo G, Mao X, Wang P, Liu B, Zhang X, Jiang X, et al. The expression profile of FRAT1 in human gliomas. Brain Res. 2010;1320:152\u20138.","journal-title":"Brain Res"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-014-1254-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-014-1254-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-014-1254-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T07:48:05Z","timestamp":1566028085000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-014-1254-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["1254"],"URL":"https:\/\/doi.org\/10.1007\/s12094-014-1254-y","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"type":"print","value":"1699-048X"},{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2014,11,12]]}}}